Evidence map›Paper›PMID 28414310›Full record

ArticleOncogene2017

Autophagy supports generation of cells with high CD44 expression via modulation of oxidative stress and Parkin-mediated mitochondrial clearance.

K A Whelan, P M Chandramouleeswaran, K Tanaka, M Natsuizaka, M Guha, S Srinivasan, D S Darling, Y Kita, S Natsugoe, J D Winkler and 5 more

Abstract read
In one paragraph

Article in Oncogene, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 92 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. CD44 signaling in skin wound healing and regeneration.Journal of translational medicine · 2025
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Cancer stem cell fate determination: mito-nuclear communication.Cell communication and signaling : CCS · 2023
    Review
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

K A WhelanDivision of Gastroenterology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA.
P M ChandramouleeswaranDivision of Gastroenterology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA.
K TanakaDivision of Gastroenterology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA.
M NatsuizakaDivision of Gastroenterology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA.
M GuhaDepartment of Animal Biology, Mari Lowe Center for Comparative Oncology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, USA.
S SrinivasanDepartment of Animal Biology, Mari Lowe Center for Comparative Oncology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, USA.
D S DarlingDepartment of Oral Immunology and Infectious Diseases, and Center for Genetics and Molecular Medicine, University of Louisville, Louisville, USA.
Y KitaDepartment of Digestive Surgery, Breast and Thyroid Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
S NatsugoeDepartment of Digestive Surgery, Breast and Thyroid Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
J D WinklerUniversity of Pennsylvania Abramson Cancer Center, Philadelphia, USA.
A J Klein-SzantoHistopathology Facility and Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, USA.
R K AmaravadiUniversity of Pennsylvania Abramson Cancer Center, Philadelphia, USA.
N G AvadhaniDepartment of Animal Biology, Mari Lowe Center for Comparative Oncology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, USA.
A K RustgiDivision of Gastroenterology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA.
H NakagawaDivision of Gastroenterology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA.
University of Pennsylvania · USKagoshima University · JPFox Chase Cancer Center · USUniversity of Louisville · US

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Dietmar J Kappes · 1985 to 2026
$138.8M
Targeting the MAP and PI3 Kinase Pathways in MelanomaP01CA114046 · NCI · WISTAR INSTITUTE · PI MURPHY, MAUREEN E. · 2008 to 2023
$37.1M
Translational Research Support CoreP30ES013508 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI Trevor M Penning · 2006 to 2026
$35.3M
TRANSGENIC AND CHIMERIC MOUSE COREP30DK050306 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI REBECCA G WELLS · 1997 to 2026
$32.5M
Transformed Esophageal Epithelial Cells and the Tumor MicroenvironmentP01CA098101 · NCI · UNIVERSITY OF PENNSYLVANIA · PI HIBSHOOSH, HANINA · 2003 to 2023
$31.7M
UNIVERSITY OF PENNSYLVANIA TRAINING IN GASTROENTEROLOGYT32DK007066 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI JONATHAN P KATZ · 1986 to 2026
$11.7M
The functional role of mitophagy in esophageal cell biologyK01DK103953 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI WHELAN, KELLY A · 2015 to 2019
$637k
Role of Notch 1 signaling in esophageal carcinogenesisF32CA174146 · NCI · UNIVERSITY OF PENNSYLVANIA · PI WHELAN, KELLY A · 2013 to 2015
$118k
Integrative mouse pathobiology: GI epithelial biology and geneticsK26RR032714 · NCRR · UNIVERSITY OF PENNSYLVANIA · PI NAKAGAWA, HIROSHI · 2011 to 2011
$87k
Total Synthesis of Plocamium Polyhalogenated Monoterpenes, Analogues, and BiologiF31CA174176 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI VOGEL, CARL · 2013 to 2015
$83k
NCI NIH HHS F31 CA174176NCI NIH HHS F32 CA174146NCI NIH HHS P01 CA098101NCI NIH HHS P01 CA114046NCI NIH HHS P30 CA006927NCRR NIH HHS K26 RR032714NIDDK NIH HHS K01 DK103953NIDDK NIH HHS P30 DK050306NIDDK NIH HHS T32 DK007066NIEHS NIH HHS P30 ES013508
6 · The paper itself

Abstract

High CD44 expression is associated with enhanced malignant potential in esophageal squamous cell carcinoma (ESCC), among the deadliest of all human carcinomas. Although alterations in autophagy and CD44 expression are associated with poor patient outcomes in various cancer types, the relationship between autophagy and cells with high CD44 expression remains incompletely understood. In transformed oesophageal keratinocytes, CD44

Indexed as

AutophagyCarcinoma, Squamous CellCell Line, TumorEpithelial-Mesenchymal TransitionEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaHumansHyaluronan ReceptorsKeratinocytesMitochondriaOxidation-ReductionOxidative StressRNA InterferenceTransforming Growth Factor betaUbiquitin-Protein LigasesCD44 protein, humanHyaluronan Receptorsparkin proteinTransforming Growth Factor betaUbiquitin-Protein Ligases

Identifiers

PMID28414310
PMCPMC5570661
OpenAlexW2607389896

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.